The strength of Ayurveda is in prevention and if we are able to prevent our youngest population from getting infected by COVID
Mumbai: The Ayurveda industry, an ancient healthcare system, is fast adopting modern scientific tools and medical technologies keeping its original treatment procedures and theories intact.
Speaking at a virtual two day conference organised by the Kerala-headquartered India’s leading ayurvedic firm, Vaidyaratnam Group, Dr. Tanuja Nesari, Director of All India Institute of Ayurveda (AIIA) of New Delhi said,“With the prospects of a third wave of COVID-19 and its likely impact on children, practitioners of this traditional healthcare form are emphasising on more and more usage of modern technologies including MRI, CT Scan, ventilators, RT-PCR tests among others.”
“The strength of Ayurveda is in prevention and if we are able to prevent our youngest population from getting infected by COVID, that’s a great achievement.” Synergy between traditions supported by technology is the new normal that we have to take forward, she added.
The virtual conference was organised by Vaidyaratnam Groupas part of its founder’s commemoration day.
Dr.Nesari mentioned that a whopping 99.99 per cent of the patients who were treated for COVID had recovered well at AIIA’s COVID-care centre.
Sharing her experience about treating COVID patients on the second day of the conference, Dr.Nesari said that each and every patient was supported by yoga, diet, lifestyle, recreation along with technology.
“So, we have retained the classical crux, the principle theory and practices of Ayurveda, developed our own holistic treatment protocol and it’s all supported by conventional bio-medical tools of investigation like MRI, CT Scan, ventilators, RT-PCR test, oxygen therapists. “I’m really proud to say that of all the patients that we have admitted, 99.99 per cent have fully recovered,” she said.
The judicious usage of advancements in other streams of science has helped validating Ayurveda in the global platform, where the tag ‘traditional medicine’ got replaced with ‘evidenced based medicine’, said AshtavaidyanDr. E.T. NeelakandhanMooss, Director of Vaidyaratnam Group.
He described Vaidyaratnam Ayurveda Research Institute (VARI) as a place where the integration of Ayurveda and the latest technologies take place and said that the advancement in the field of Ayurvedic raw Dr.ug agriculture using ‘Miyawaki’ method to the identification of new Dr.ug delivery systems are backed up by the latest trends of science and technology.
“Thus, the Vaidyaratnam Group has always been trying to scientifically update its different verticals like cultivation, medicine manufacturing, process validation, Dr.ug discovery and healthcare without losing its quality,” he said.
According to a global study published by Lancet, a peer reviewed medical journal, around 20 per cent of the COVID positive children remained asymptomatic. However, the scenario in India was completely different with as much as 60-70 per cent children turning asymptomatic.
This, according to Ayurveda experts, underscores the need for preventive medications as soon as a member of a family turns COVID positive.
VaidyaratnamOushadhasala is managed by the ThaikkatusseriEledathuThaikkatu Family, one among the renowned Ashtavaidya families of Kerala. Ashtavaidyas are physicians who are masters of the eight branches of Ayurveda mentioned in classical texts. Every year, the Vaidyaratnam group observes July 12 as its Founder’s Commemoration Day in memory of Late Ashtavaidyan Padma Shri EledathThaikkattuNeelakandhanMooss who established the institution in 1941. The group has an Ayurvedic pharmaceutical division, R&D, Ayurveda hospital, Ayurveda medical college, Ayurveda Museum, Treatment centres and Clinics located across India. It provides Ayurveda treatment and medicines across the length and breadth of India through 2,000 centres and franchises.